Chlamydia trachomatis and Neisseria gonorrhoeae by Transcription-Mediated Amplification (TMA), ThinPrep

Also known as: CG MATP

Clinical Use

Use

This test is used to detect the presence of Chlamydia trachomatis and Neisseria gonorrhoeae in ThinPrep specimens. It is performed using Transcription-Mediated Amplification (TMA), a sensitive nucleic acid amplification technique. The test is intended for medical purposes to diagnose infections but is not suitable for evaluating suspected sexual abuse or for forensic use. Positive results may require confirmation through alternative nucleic acid targets, depending on clinical context and regulatory requirements.

Special Instructions

Not provided.

Limitations

The test does not confirm positive results with an alternative nucleic acid target, which might be necessary per clinical guidelines or legal requirements, especially in cases where culture is required for diagnosis. Inadequate specimen collection, transport, or handling may lead to inaccurate results. The reliability of the test outside its intended use or patient population is not established.

Test Details

New York Approved

Methodology

PCR-based (Transcription-Mediated Amplification (TMA))

Biomarkers

2 components

C. trachomatis by TMA, ThinPrep • Transcription-Mediated Amplification (TMA)N. gonorrhoeae by TMA, ThinPrep • Transcription-Mediated Amplification (TMA)

LOINC Codes

Order Codes

31208-2 - Specimen source
43304-5 - C trach rRNA Spec Ql NAA+probe
43305-2 - N gonorrhoea rRNA Spec Ql NAA+probe

Result Codes

43304-5 - C trach rRNA Spec Ql NAA+probe
43305-2 - N gonorrhoea rRNA Spec Ql NAA+probe

Result Turnaround Time

1-4 days

Specimen

Cervical Swab

Volume

1 mL

Minimum Volume

Not provided

Container

APTIMA Specimen Transfer Tube

Collection Instructions

Use the ThinPrep Pap Test Collection Kit to obtain a cervical specimen. Vortex the ThinPrep PreservCyt solution and transfer 1 mL to an APTIMA Specimen Transfer Tube.